Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

2609
Delayed Quote. Delayed Euronext Paris - 02/27 11:36:08 am
87.7 EUR   +0.18%
02/27 SANOFI : Toujeo® Receives Positive Opinion from the European Regulat..
02/26 SANOFI : Good Morning Sanofi - Tom Blount
02/25DJSanofi Wins Approval For New Insulin Drug
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi: Tests Show Zaltrap Improves Colorectal Cancer Survival Rate

10/08/2012 | 01:44am US/Eastern

French drug company Sanofi SA (>> SANOFI) Monday said results from the pivotal Phase III Velour study evaluating Zaltrap showed improvement in overall survival rate to colorectal cancer.

MAIN FACTS:

- Sanofi said the Journal of Clinical Oncology published the results of the study evaluating Zaltrap effects.

- In the Velour trial evaluating metastatic colorectal cancer patients previously treated with an oxaliplatin-containing regimen, Zaltrap in combination with the Folfiri chemotherapy regimen (5-fluorouracil, leucovorin, irinotecan) showed a statistically significant improvement in overall survival, progression-free survival, and the overall tumor response rate versus placebo plus Folfiri.

- The Velour data supported the regulatory approval of Zaltrap by the U.S. Food and Drug Administration (FDA) on August 3, 2012 after a Priority Review.

- Zaltrap is under review at the European Medicines Agency and other regulatory agencies worldwide, Sanofi says.

-Write to Inti Landauro at inti.landauro@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : SANOFI
React to this article
Latest news on SANOFI
02/27 SANOFI : Toujeo® Receives Positive Opinion from the European Regulatory Authorit..
02/26 SANOFI : Good Morning Sanofi - Tom Blount
02/25DJSanofi Wins Approval For New Insulin Drug
02/25DJSanofi Wins Approval For New Insulin Drug
02/25 GENZYME : Patent Application Titled "Methods of Treating Autoimmune Diseases" Pu..
02/25 SANOFI : Receives FDA Approval of Once-Daily Basal Insulin Toujeo®
02/25 SANOFI : Researchers from Sanofi Describe Findings in Gastric Cancer [A Phase I ..
02/25 GENZYME : ENGAGE Randomized Clinical Trial Evaluating Cerdelga® eliglustat for T..
02/24 SANOFI : Socialists blast Sanofi chief's €4m welcome
02/24DJBOND REPORT : Treasury Fall As Yellen Sets Timetable For Removal Of 'patient'
Advertisement
Chart
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF